State Street Corp Corcept Therapeutics Inc Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, State Street Corp holds 3,519,263 shares of CORT stock, worth $202 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,519,263
Previous 3,499,370 0.57%
Holding current value
$202 Million
Previous $114 Million 43.19%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$29.51 - $46.26 $587,042 - $920,250
19,893 Added 0.57%
3,519,263 $163 Million
Q2 2024

Aug 14, 2024
SELL
$22.21 - $34.48 $1.69 Million - $2.63 Million
-76,156 Reduced 2.13%
3,499,370 $114 Million
Q1 2024

May 15, 2024
BUY
$21.1 - $27.46 $3.97 Million - $5.16 Million
188,061 Added 5.55%
3,575,526 $90.1 Million
Q4 2023

Feb 14, 2024
BUY
$24.82 - $32.88 $6.07 Million - $8.04 Million
244,414 Added 7.78%
3,387,465 $110 Million
Q3 2023

Nov 14, 2023
SELL
$21.97 - $33.8 $510,648 - $785,613
-23,243 Reduced 0.73%
3,143,051 $85.6 Million
Q2 2023

Aug 14, 2023
SELL
$21.44 - $25.15 $2.67 Million - $3.13 Million
-124,611 Reduced 3.79%
3,166,294 $70.5 Million
Q1 2023

May 15, 2023
BUY
$19.2 - $24.47 $1.77 Million - $2.26 Million
92,211 Added 2.88%
3,290,905 $71.3 Million
Q4 2022

Feb 14, 2023
SELL
$19.95 - $29.96 $5.28 Million - $7.94 Million
-264,904 Reduced 7.65%
3,198,694 $65 Million
Q3 2022

Nov 15, 2022
SELL
$24.7 - $29.12 $885,445 - $1.04 Million
-35,848 Reduced 1.02%
3,463,598 $88.8 Million
Q2 2022

Aug 15, 2022
BUY
$17.33 - $25.3 $1.56 Million - $2.27 Million
89,888 Added 2.64%
3,499,446 $83.2 Million
Q1 2022

May 16, 2022
BUY
$16.53 - $25.21 $1.67 Million - $2.55 Million
101,078 Added 3.06%
3,409,558 $76.8 Million
Q4 2021

Feb 14, 2022
BUY
$17.1 - $23.34 $611,102 - $834,101
35,737 Added 1.09%
3,308,480 $65.5 Million
Q3 2021

Nov 15, 2021
SELL
$19.68 - $22.53 $179,658 - $205,676
-9,129 Reduced 0.28%
3,272,743 $64.4 Million
Q2 2021

Aug 16, 2021
BUY
$19.97 - $24.43 $1.18 Million - $1.44 Million
58,915 Added 1.83%
3,281,872 $72.2 Million
Q1 2021

May 17, 2021
SELL
$23.49 - $30.56 $175,587 - $228,436
-7,475 Reduced 0.23%
3,222,957 $76.7 Million
Q4 2020

Feb 16, 2021
BUY
$16.78 - $27.3 $1.05 Million - $1.7 Million
62,341 Added 1.97%
3,230,432 $84.5 Million
Q3 2020

Nov 10, 2020
SELL
$12.46 - $19.98 $1.51 Million - $2.42 Million
-121,102 Reduced 3.68%
3,168,091 $55.1 Million
Q2 2020

Aug 14, 2020
BUY
$11.0 - $18.26 $1.26 Million - $2.09 Million
114,590 Added 3.61%
3,289,193 $55.3 Million
Q1 2020

May 11, 2020
BUY
$10.11 - $14.04 $32.1 Million - $44.6 Million
3,174,603 New
3,174,603 $37.7 Million

Others Institutions Holding CORT

# of Institutions
347
Shares Held
86.6M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.16B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email